Richard W. Thomas
Director/Miembro de la Junta en EpiWatch, Inc. .
Perfil
Richard W.
Thomas is currently the Director at EpiWatch, Inc. since 2022.
Prior to this, he worked as the Chief Medical Officer at Defense Health Agency.
Cargos activos de Richard W. Thomas
Empresas | Cargo | Inicio |
---|---|---|
EpiWatch, Inc.
EpiWatch, Inc. Internet Software/ServicesTechnology Services EpiWatch, Inc. is a company founded by Nathan Crone and Gregory professors of neurology and epileptologists at the Johns Hopkins School of Medicine. The company is based in Baltimore, MD and uses technology licensed from Johns Hopkins. EpiWatch aims to lead the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition, and provide peace of mind for their loved ones. The company is initially developing a proprietary capability to detect and alert for potentially dangerous tonic-clonic (grand mal) seizures. EpiWatch is leading the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition. Dean Papadopoulos has been the CEO of the company since 2020. | Director/Miembro de la Junta | 07/04/2022 |
Antiguos cargos conocidos de Richard W. Thomas.
Empresas | Cargo | Fin |
---|---|---|
Defense Health Agency | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Defense Health Agency | Government |
EpiWatch, Inc.
EpiWatch, Inc. Internet Software/ServicesTechnology Services EpiWatch, Inc. is a company founded by Nathan Crone and Gregory professors of neurology and epileptologists at the Johns Hopkins School of Medicine. The company is based in Baltimore, MD and uses technology licensed from Johns Hopkins. EpiWatch aims to lead the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition, and provide peace of mind for their loved ones. The company is initially developing a proprietary capability to detect and alert for potentially dangerous tonic-clonic (grand mal) seizures. EpiWatch is leading the digital transformation of epilepsy care by delivering innovative and integrated services that keep people with epilepsy safe, enable them, their caregivers, and their physicians to better manage their condition. Dean Papadopoulos has been the CEO of the company since 2020. | Technology Services |
- Bolsa de valores
- Insiders
- Richard W. Thomas